journal article·2025-04

Platinum Nanozyme‐Loaded Dissolving Microneedles Scavenge ROS and Promote Lineage Progression for Androgenetic Alopecia Treatment

Weitong Hu, Shuhan Shi, Yihua Xu, Yunting Zhang, Jingyi Hu, Qiong Bian, Xiaolu Ma, Yuxian Ye, Shengfei Yang, Xiaoxia Sheng, Guang Liang, Tianyuan Zhang, Haibin Wu, Jianqing Gao

Small Methods· Volume 9· Issue 4
Publisher page

Abstract

Abstract Androgenetic alopecia (AGA) is a prevalent issue affecting the physical and mental health of individuals but with fewer current treatments. Platinum nanozymes (PtNZs) are known for their excellent ability to reduce and modulate the high oxidative stress environment in AGA pathology. And microneedles are used to overcome the skin barrier due to the poor permeability of PtNZs. Herein, dissolving microneedles loaded with PtNZs (Pt‐MNs) are designed and successfully induced hair regeneration in the AGA model. Pt‐MNs possessed adequate mechanical strength to breach the skin barrier for effective PtNZs delivery. In vivo, PtNZs first reduced reactive oxygen species (ROS) to oxygen, which recovered the AGA pathological environment. And the oxygen then increased oxidative phosphorylation, promoting the differentiation of hair follicle stem cells to achieve hair regeneration. The group treated with Pt‐MNs with a dosing frequency of once every three days achieved faster hair growth than the daily application of the positive drug minoxidil. Further safety experiments showed that the application of Pt‐MNs locally opened temporary and recoverable skin channels, with no retention of Pt in major organs, indicating high safety. In conclusion, this study indicated the potential of Pt‐MNs as an effective method for treating AGA.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Dermatologic Treatments and Research · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Advanced Drug Delivery and Release Systems College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 China

School of Pharmaceutical Sciences Hangzhou Medical College Hangzhou 311399 China

Hangzhou SoliPharma Co. Ltd Hangzhou 311399 China

Department of Pharmacy the Second Affiliated Hospital School of Medicine Zhejiang University Hangzhou 310009 China

Jiangsu Engineering Research Center for New‐type External and Transdermal Preparations Changzhou 213149 China

Funding

National Natural Science Foundation of China

References (37)

Show source-provided references
1. 10.1038/s41467-017-01490-810.1038/s41467-017-01490-8 ↗
2. 10.1021/acsnano.8b0957310.1021/acsnano.8b09573 ↗
3. 10.1046/j.1365-2133.1999.03030.x10.1046/j.1365-2133.1999.03030.x ↗
4. 10.1016/j.jid.2016.03.03210.1016/j.jid.2016.03.032 ↗
5. 10.1038/ncomms1469410.1038/ncomms14694 ↗
6. 10.1186/s13619-022-00122-x10.1186/s13619-022-00122-x ↗
7. 10.1080/09546634.2021.194552710.1080/09546634.2021.1945527 ↗
8. 10.2174/18722131280016685910.2174/187221312800166859 ↗
9. 10.1007/s40257-018-0409-y10.1007/s40257-018-0409-y ↗
10. 10.2165/00002018-199410040-0000510.2165/00002018-199410040-00005 ↗
11. 10.2165/00003495-200161010-0000610.2165/00003495-200161010-00006 ↗
12. 10.1016/S0190-9622(84)70183-610.1016/S0190-9622(84)70183-6 ↗
13. 10.1038/jid.2015.2810.1038/jid.2015.28 ↗
14. 10.1021/acsnano.1c0527210.1021/acsnano.1c05272 ↗
15. 10.1016/j.jdermsci.2017.01.00310.1016/j.jdermsci.2017.01.003 ↗
16. 10.1038/s41580-023-00662-310.1038/s41580-023-00662-3 ↗
17. 10.1038/nnano.2007.26010.1038/nnano.2007.260 ↗
18. 10.1021/acs.est.3c0086410.1021/acs.est.3c00864 ↗
19. 10.3390/ijms2509493310.3390/ijms25094933 ↗
20. 10.1002/anie.20120378010.1002/anie.201203780 ↗
21. 10.1021/acs.analchem.3c0324910.1021/acs.analchem.3c03249 ↗
22. 10.1039/C8CS00718G10.1039/C8CS00718G ↗
23. 10.1002/adfm.20231558710.1002/adfm.202315587 ↗
24. 10.1002/smll.20220640810.1002/smll.202206408 ↗
25. 10.1016/j.jconrel.2022.05.04510.1016/j.jconrel.2022.05.045 ↗
26. 10.1080/0954663080251267910.1080/09546630802512679 ↗
27. 10.1016/j.ijpharm.2021.12059810.1016/j.ijpharm.2021.120598 ↗
28. 10.1016/j.actbio.2022.02.01110.1016/j.actbio.2022.02.011 ↗
29. 10.1038/s41467-019-09402-810.1038/s41467-019-09402-8 ↗
30. 10.1159/00050615510.1159/000506155 ↗
31. 10.1016/j.cmet.2020.08.01110.1016/j.cmet.2020.08.011 ↗
32. 10.1080/15476278.2020.179427110.1080/15476278.2020.1794271 ↗
33. 10.1002/anie.20110183310.1002/anie.201101833 ↗
34. 10.1002/adma.20200356310.1002/adma.202003563 ↗
35. 10.1007/s10529-006-9219-z10.1007/s10529-006-9219-z ↗
36. 10.1021/acsnano.1c0622510.1021/acsnano.1c06225 ↗
37. 10.1201/9781003109228-1710.1201/9781003109228-17 ↗